MedPath
NMPA Approval

复方珍珠口服液

国药准字B20020243

August 7, 2020

国药准字B20020243

Drug Information

复方珍珠口服液

合剂

每支装10ml(含牛磺酸0.20g)

中药

August 7, 2020

Company Information

Applicant Company

湖北省黄冈市团风县城南工业园团黄大道一号

Manufacturing Company

湖北省黄冈市团风县城南工业园团黄大道一号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方珍珠口服液 - NMPA 批准文号 | MedPath